Low Endotoxin Basic Fibroblast Growth Factor bFGF Lyophilized Powder Plant Derived

Low Endotoxin Basic Fibroblast Growth Factor bFGF Lyophilized Powder Plant Derived ​

Description

As an expression platform with rice endosperm cell as the carrier, it has a great advantage compared with the bacteria bioreactor. Firstly,, rice is a self – pollination crop, greatly guarantee the genetic stability; Secondly, there is almost sterile condition in the endosperm cells, which is easy to purify it and avoid some bacteria themselves impurities. Thereby, Healthgen Biotech recombinant bFGF has less endotoxin level, which is less than 1EU/ug. It is very useful for the cell culture, especially stem cell, and cosmetics use.

Quick Details

1. CAS No.: 106096-93-9
2. Other Names: Plant-derived bFGF, OsrhbFGF, rbFGF, recombinant bFGF, bFGF, FGF2, FGF-β
3. EINECS No.: 274-272-6
4. Place of Origin: Wuhan, China (Mainland)
5. Brand Name: Oryzogen
6. Model Number: HYC005M01
7. Purity: Greater than 95% as determined by SDS-PAGE.
8. Restrictions: FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY

Advantages

1. Healthgen Biotech quality control systerm has been certified by ISO 9001:2015 and ensure standardized process as well as qualified products.

2. Healthgen Biotech recombinant bFGF(OsrhbFGF) is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.

3. Healthgen Biotech OsrhbFGF has excellent batch consistency. Using self-pollination rice as the bioreactor to express the OsrhbFGF, with the world's advanced facility and top production proceeding to extract and purify the OsrhbFGF, Healthgen Biotech can ensure the excellent consistency of OsrhbFGF from different batches. 

Supplemental Description

Achievement and Honor

Healthgen Biotech obtained a number of patented technologies with independent intellectual property rights, including applied 9 national patents and 6 authorized patents, applied 7 international patents and 3 authorized patents. The international patents cover to United States, Japan, Europe and Canada. Moreover, two patents were authorized both by the Republic of South Africa and the United States. Based on rice endosperm specific expression technical platform-Oryz^HiExp, Healthgen Biotech, aim at the international forefront, takes the market as the orientation and enhances biotechnology innovation and engineering research, has won numerous awards.

Scientific Research Projects:

Major projects for New Drug Discovery, 3 projects of "Major projects of new varieties of genetically modified organisms” of the Ministry of Agriculture, National Ministry of Science and high Technology “863 plan”, National Ministry of Science and Technology Innovation fund, Pilot development of strategic emerging industries project

Talents Scheme:

“Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province, "3551 talents program” of the East Lake high-technology development zone , Top 10 "Venture Eagle" entrepreneurs.

Research Centers and Awards:

Wuhan National Biological Industry Base protein purification center, Hubei Molecular Biopharmaceutical Engineering Research Center, 2013 National Science and Technology Invention Award, 2012 Hubei Provincial Science and Technology Invention Award, 2013 China Patent Excellence Award, High-tech enterprise, Agricultural science and technology enterprise, Patent advantage enterprise.